Treatment of metastatic tumors of the urogenital area with cytokine-induced killer cells

Treatment of metastatic tumors of the urogenital area using autologous cytokine-induced killer cells

Inclusion Criteria:

• Histologically confirmed diagnosis of pTa metastatic tumors of the urogenital area;
• Patient who require repetitive transurethral resection;
• Expression of muc-1/wt-1 by the tumor;
• EGOC 0-3;

Exclusion Criteria:

• any medical condition which can be associated with the high risk for the patient;
• pregnancy/lactation;
• chronic infections, including hepatitis B/C, tuberculosis, HIV